Autocrine IL-10 Impairs Dendritic Cell (DC)-derived Immune Responses to Mycobacterial Infection by Suppressing DC Trafficking to Draining Lymph Nodes and Local IL-12 Production
Overview
Affiliations
The production of IL-12 by dendritic cells (DC) early in an immune response is considered critical for the polarization of CD4(+) T lymphocyte response towards a Th1 pattern, a key process in the clearance of intracellular pathogens. Infection of bone marrow-derived DC with Mycobacterium bovis Bacillus Calmette Guérin (BCG) induced a concurrent and dose-dependent releaseof IL-10 and IL-12. Here we examined whether the production of IL-10 by DC affected their IL-12 response to mycobacterial infection and the generation of protective immune responses in vivo. Compared to wild-type (WT) DC, DC deficient for IL-10 synthesis (IL-10(-/-)) showed increased IL-12 production in response to BCG infection and CD40 stimuli in vitro. Moreover, when transferred into mice, infected IL-10(-/-) DC were more efficient than WT DC at inducing IFN-gamma production to mycobacterial antigens in the draining lymph nodes (DLN). This effect was associated with increased trafficking of IL-10(-/-) DC to the DLN and enhanced IL-12 production by DC within the DLN. These data show that autocrine IL-10 exerts a dual inhibitory effect on the induction of primary immune responses by DC: first, by down-regulating the migration of infected DC to the DLN and second, by modulating the IL-12 production by DC in the DLN.
The dual role of cannabidiol on monocyte-derived dendritic cell differentiation and maturation.
Penzes Z, Alimohammadi S, Horvath D, Olah A, Toth B, Bacsi A Front Immunol. 2023; 14:1240800.
PMID: 37680639 PMC: 10482398. DOI: 10.3389/fimmu.2023.1240800.
Canine Distemper Virus Alters Defense Responses in an Ex Vivo Model of Pulmonary Infection.
Chludzinski E, Ciurkiewicz M, Stoff M, Klemens J, Kruger J, Shin D Viruses. 2023; 15(4).
PMID: 37112814 PMC: 10144441. DOI: 10.3390/v15040834.
Koshkin I, Vlasenko V, Pleshakova V, Alkhimova L, Elyshev A, Kulakov I Vaccines (Basel). 2022; 10(12).
PMID: 36560494 PMC: 9784198. DOI: 10.3390/vaccines10122084.
Dos Santos C, Vacani-Martins N, Cascabulho C, Pereira M, Crispe I, Henriques-Pons A Front Immunol. 2022; 13:868574.
PMID: 35720410 PMC: 9204308. DOI: 10.3389/fimmu.2022.868574.
Natural killer cells: a promising immunotherapy for cancer.
Chu J, Gao F, Yan M, Zhao S, Yan Z, Shi B J Transl Med. 2022; 20(1):240.
PMID: 35606854 PMC: 9125849. DOI: 10.1186/s12967-022-03437-0.